MUTYH Gene Mutation Analysis (Y165C and G382D) for MUTYH associated polyposis (MAP)
Ehrlichia Antibody, Western Blot
Cytochrome P450 2B6 (CYP2B6) Genotyping
West Nile Virus (WNV) Antibody, IgG and IgM, CSF
Nefazodone, Urine
HER2/neu (ERBB2), IHC, Semi Quantitative, Automated
Varicella Zoster Virus (VZV) Antibody, IgG, CSF
Carbamazepine, Total, Serum
Alveolar Soft Part Sarcoma (ASPS)/Renal Cell Carcinoma (RCC), Xp11.23 (TFE3), FISH, Tissue
HLA Class II Typing, Antigen or Genotyping
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Interpretation
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now